trending Market Intelligence /marketintelligence/en/news-insights/trending/fmzfwaeeryrz7u4yxqwd7q2 content esgSubNav
In This List

VTv Therapeutics secures $2.5M investment

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


VTv Therapeutics secures $2.5M investment

High Point, N.C.-based vTv Therapeutics Inc. received a $2.5 million investment from MacAndrews & Forbes Group LLC.

The drug developer exercised its right — part of a July 30 agreement — to have the investor acquire 1,879,699 of its class A common shares at $1.33 each.

VTv Therapeutics discovers, develops and sells orally administered small molecule drug candidates.